Pages that link to "Q78175792"
Jump to navigation
Jump to search
The following pages link to Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group (Q78175792):
Displaying 50 items.
- Balance training in stroke patients – a systematic review of randomized, controlled trials (Q22337183) (← links)
- Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients (Q24187385) (← links)
- Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients (Q24244091) (← links)
- Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease (Q24244250) (← links)
- Outcomes, Outcomes, Every where, nor any Stop to Think? (Q24289467) (← links)
- Back to thiazide-diuretics for hypertension: reflections after a decade of irrational prescribing (Q24805075) (← links)
- Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention? (Q26830804) (← links)
- End points for comparative effectiveness research in heart failure (Q27012843) (← links)
- Drugs to Enhance Motor Recovery After Stroke (Q28088317) (← links)
- DVT prophylaxis and anticoagulation in the surgical patient (Q28194897) (← links)
- Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy (Q28475480) (← links)
- Surrogate outcomes in neurology, psychiatry, and psychopharmacology (Q30473416) (← links)
- Randomized controlled trials in pediatric critical care: a scoping review (Q30580682) (← links)
- Functional magnetic resonance imaging in stroke recovery (Q30775227) (← links)
- Resident utilization of information technology (Q31043500) (← links)
- Searching for evidence-based medicine in the literature. Part 3: Assessment (Q33218792) (← links)
- Evidence-based medicine. Interpreting studies and setting policy (Q33334905) (← links)
- Benefit and pitfalls in the use of data from surrogate endpoint trials for clinical decision making (Q33626699) (← links)
- Randomized clinical trial comparing efficacy and safety of brand versus generic alendronate (Bonmax®) for osteoporosis treatment (Q33874055) (← links)
- Current methods of the US Preventive Services Task Force: a review of the process (Q33942708) (← links)
- Primary cancer prevention trials (Q34009185) (← links)
- Cancer screening (Q34009189) (← links)
- Biomarkers of acute lung injury: worth their salt? (Q34094906) (← links)
- Homocysteine and its relationship to deep venous thrombosis in patients undergoing total knee or hip arthroplasty (Q34144981) (← links)
- Harnessing neuroplasticity for clinical applications (Q34177415) (← links)
- Toward a definition of pharmaceutical innovation (Q34186669) (← links)
- The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseases (Q34518494) (← links)
- Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study (Q34567058) (← links)
- Prevalence of subthreshold hypomania and impact on internal validity of RCTs for major depressive disorder: results from a national epidemiological sample (Q34584230) (← links)
- Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease (Q34636461) (← links)
- The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials (Q34727099) (← links)
- Epidemiologic analyses of risk factors, risk indicators, risk markers, and causal factors. The example of albuminuria and the risk of cardiovascular disease in diabetes (Q34845567) (← links)
- Principles of preventive care (Q35046179) (← links)
- Generalizability of pharmacological and psychotherapy clinical trial results for borderline personality disorder to community samples (Q35214927) (← links)
- How to spot bias and other potential problems in randomised controlled trials (Q35478926) (← links)
- Endpoint Selection and Relative (Versus Absolute) Risk Reporting in Published Medication Trials (Q35527067) (← links)
- Novel Outcomes and End Points: Biomarkers in Chronic Obstructive Pulmonary Disease Clinical Trials (Q35532191) (← links)
- Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials (Q35629103) (← links)
- Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy (Q35792872) (← links)
- Evidence from biomarkers and surrogate endpoints (Q36045330) (← links)
- Evidence from clinical trials: can we do better? (Q36045358) (← links)
- How to read a clinical trial paper: a lesson in basic trial statistics. (Q36049663) (← links)
- Kinematic measures of Arm-trunk movements during unilateral and bilateral reaching predict clinically important change in perceived arm use in daily activities after intensive stroke rehabilitation (Q36081963) (← links)
- Recent advances in biomarkers for cancer diagnosis and treatment (Q36196830) (← links)
- The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease (Q36302399) (← links)
- Use of surrogate outcomes in US FDA drug approvals, 2003-2012: a survey. (Q36329179) (← links)
- World Workshop on Oral Medicine IV: Process and methodology for systematic review and developing management recommendations. Reference manual for management recommendations writing committees. (Q36767139) (← links)
- Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial (Q36790120) (← links)
- Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate (Q36979311) (← links)
- Acute kidney injury: Better biomarkers and beyond (Q37109954) (← links)